US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biologics Market Research Reports & Industry Analysis

A biologic medical product or a biologic or biological, is a medicinal product such as a vaccine, blood or blood component, gene therapy, tissue, recombinant therapeutic protein, or living cells that are used as therapeutics to treat diseases. Biologics are created by biologic processes, rather than being chemically synthesized. Biologics can be composed of sugars, proteins, or nucleic acids or a complex combination of these substances.
They may be living entities such as cells and tissues. Biologics are isolated from a variety of natural sources that can be human, animal, or microorganism.
RSS Feeds

Biologics Industry Research & Market Reports

< prev 1    3  4  5  6  
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2022, NAIC 325414
8/25/2015 | published by: Plunkett Research, Ltd.
... will save countless hours of research. Key Findings: Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.) to reach $44.4 billion by 2022. Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry, including Average EBITDA, Operating ...  |  read more...
USD 1,995
Global Biologic Therapeutic Drugs Industry 2015 Market Research Report
8/13/2015 | published by: QYResearch Group
... industry including definitions, classifications, applications and industry chain structure.The Biologic Therapeutic Drugs market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans ...  |  read more...
USD 2,800
Global Next-Generation Biologics Industry 2015 Market Research Report
8/7/2015 | published by: QYResearch Group
... definitions, classifications, applications and industry chain structure.The Next-Generation Biologics market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as ...  |  read more...
USD 2,800
12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
8/1/2015 | published by: BioPlan Associates, Inc.
... manufacturing organizations' current and projected future capacity and production. The report contains the industry's definitive, quantitative analysis and includes 12 years of biopharma trends as well as a review of current opportunities and in-depth coverage ...  |  read more...
USD 895
Global Single-use Bioprocessing System Market 2015-2019
7/29/2015 | published by: TechNavio - Infiniti Research Ltd.
... process that utilize living cells or their components such as enzymes, bacteria, and others to obtain preferred products. The central idea behind the usage of single-use bioprocessing technology in the bioprocess is to decrease the ...  |  read more...
USD 2,500
Global Biocatalysis & Biocatalysts Industry Report 2015
8/4/2015 | published by: QYResearch Group
... definitions, classifications, applications and industry chain structure.The Biocatalysis & Biocatalysts market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed ...  |  read more...
USD 2,800
Conference Documentation: Lyophilisation -Europe
6/30/2015 | published by: SMI Publishing, Ltd
... of biological products, and an invaluable tool for prolonging shelf life and stability for biological drugs and vaccines. As under met needs in drug transport and long term storage continues to prevail, robust lyophilisation methods ...  |  read more...
USD 788.78
Biologicals in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... developing 2333 biological drugs in 5702 developmental projects in cancer. In addition, there are 27 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 1017 drugs. Biologicals In ...  |  read more...
USD 11,025
Biopharmaceuticals Markets in China
7/1/2015 | published by: Asia Market Information & Development Company
... a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment ...  |  read more...
USD 4,000
Conference Documentation: Immunogenicity
6/30/2015 | published by: SMI Publishing, Ltd
... the latest updates on the prediction and reduction of immunogenicity, clinical results and interpetations and optimising bioassays. Led by selected case studies from leading drug developement teams, bioanalytical experts, and academics we aim to provide ...  |  read more...
USD 788.78
2015 Microfluidic Applications in the Pharmaceutical, Life Sciences, In-Vitro Diagnostic, and Medical Device Markets
6/17/2015 | published by: Yole Developpement
... over the next five years. THE MICROFLUIDIC INDUSTRY IS NOW WELL STRUCTURED FOR FURTHER GROWTH As a logical consequence of impressive growth for several years running, the Microfluidic Industry is showing production-strengthening signs on both ...  |  read more...
USD 6,750
Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2015-2025
6/17/2015 | published by: Visiongain
... provides you with revenue forecasts to 2025 at overall world market, therapeutic class and national level. For those therapies you will receive financial data, R&D trends, opportunities and commercial prospects. Visiongain’s updated study gives you ...  |  read more...
USD 2,788
Asia Pacific Spine Surgery Devices Market by Products (Non-Fusion Implants, Spinal Fusion & Fixation Devices, Spine Biologics, Spine Bone Stimulators, Vertebral Compression Fracture Treatment Devices), by End-User, by Geography - Analysis and Forecast to
6/5/2015 | published by: MicroMarketMonitor
... 2019 Currently there are various key factors that are impacting the field of medical device. These key trends include the consolidation, focus research spending and international strategies. Though the field is becoming tougher, the spine ...  |  read more...
USD 2,650
PAREXEL Biopharmaceutical R&D Statistical Sourcebook 2015/2016
7/10/2015 | published by: Barnett Educational Services
... the latest intelligence on every aspect of biopharmaceutical development – from product discovery, to R&D performance and productivity, to time-to-market trends. With real-world analysis and key contributions from leading consultancies and experts, the Sourcebook includes: ...  |  read more...
USD 425
North America Spine Surgery Devices Market by Product (Non-Fusion Implants, Spinal Fusion and Fixation Devices, Spine Biologics, Spine Bone Stimulators, VCFT Devices), by End User (Hospitals, Orthopedic Clinics), by Geography - Analysis and Forecast to 20
5/11/2015 | published by: MicroMarketMonitor
... market, by product type, encompasses spinal fusion and fixation devices, spine biologics devices, VCF treatment devices, non-fusion implant devices, and spine bone stimulators devices. Of these, the spinal fusion and fixation devices segment is the ...  |  read more...
USD 2,650
Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025
5/18/2015 | published by: Visiongain
... will stay ahead with exclusive market data and industry knowledge, benefitting your influence. And you can explore trends, developments, results, opportunities and sales predictions. Visiongain’s new study reveals what’s possible for biological drugs – their ...  |  read more...
USD 4,648
Biopharmaceutical Contract Manufacturing Market, 2015 - 2025
5/5/2015 | published by: Roots Analysis
... to serving as a cost-cutting tool, contract manufacturing provides several other advantages to biopharmaceutical companies including technical expertise, operational efficiency, regulatory support and the ability to focus on core competencies. Spanning multiple operations within the ...  |  read more...
USD 2,199
Biologics Markets in China
6/1/2015 | published by: Asia Market Information & Development Company
... a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment ...  |  read more...
USD 4,000
Orphan Drugs (Biologics, Non-Biologics)
4/1/2015 | published by: Global Industry Analysts
... forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based ...  |  read more...
USD 4,950
European Markets For Soft Tissue Reinforcement And Regeneration
4/1/2015 | published by: iData Research, Inc.
... of the United States. Since biologic matrices are often significantly more expensive than their synthetic counterparts in Europe, the low biologic adoption rate has a substantial negative impact on the soft tissue market as a ...  |  read more...
USD 9,995
Europe Spine Surgery Devices Market by Product (Spinal Fusion & Fixation Devices, Spine Biologics, Non-Fusion Implants, Spine Bone Stimulators), by End-User (Orthopedic Clinics & Spine Centers, Hospitals), by Geography – Analysis & Forecast to 2019
5/20/2015 | published by: MicroMarketMonitor
... 2019 The European spine surgery devices market is expected to reach $2,993.6 million by 2019, at a CAGR of 7.3% from 2014 to 2019. This is mainly due to the increasing incidences of spinal deformities ...  |  read more...
USD 2,650
Biopharmaceuticals (Recombinant Protein, Monoclonal Antibodies, Insulin, and Vaccines)
5/1/2015 | published by: Global Industry Analysts
... separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these ...  |  read more...
USD 4,950
Antibody Production Market by Product (Equipment, Consumables), Type (Monoclonal, Polyclonal), Technology (Hybridoma) & by End-User (Biopharmaceutical Companies, Diagnostic Labs, Research Institutes) - Analysis & Global Forecast to 2019
5/1/2015 | published by: MarketsandMarkets
... market has witnessed various technological advancements in order to produce antibodies that meet the needs of biotechnology and biopharmaceutical companies, diagnostic laboratories, and research institutes. These advancements have led to the development of hybridoma-free technologies ...  |  read more...
USD 5,650
Biological Safety Testing Market by Application (Stem Cell, Blood, Gene Therapy), Product (Instruments, Services, Kits, Reagents), & Test (Bioburden, Endotoxin, Cell Line Authentication, Residual Contamination, Adventitious Agents) - Global Forecast to 20
4/27/2015 | published by: MarketsandMarkets
... safety testing market is growing at a favorable rate. The major drivers for the market include growth of the pharmaceutical and biological industries and an increasing number of new drug launches. Over the years, the ...  |  read more...
USD 4,650
Conference Documentation: Lyophilisation USA
4/30/2015 | published by: SMI Publishing, Ltd
... the pharmaceutical industry. This is contributing to the projected rise in investment, currently dominated by North America, which is expected to reach $4.80 billion in 2020. This rate of growth is a result of new ...  |  read more...
USD 788.78
< prev 1    3  4  5  6